| Oncogenic pathways and the electron transport chain: a dangeROS liaison V Raimondi, F Ciccarese, V Ciminale British journal of cancer 122 (2), 168-181, 2020 | 129 | 2020 |
| The miR-200 family of microRNAs: fine tuners of epithelial-mesenchymal transition and circulating cancer biomarkers I Cavallari, F Ciccarese, E Sharova, L Urso, V Raimondi, M Silic-Benussi, ... Cancers 13 (23), 5874, 2021 | 81 | 2021 |
| Nanoparticles as tools to target redox homeostasis in cancer cells F Ciccarese, V Raimondi, E Sharova, M Silic-Benussi, V Ciminale Antioxidants 9 (3), 211, 2020 | 47 | 2020 |
| mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cells M Silic-Benussi, E Sharova, F Ciccarese, I Cavallari, V Raimondi, L Urso, ... Redox biology 51, 102268, 2022 | 17 | 2022 |
| Expression of miR-34a in T-cells infected by human T-lymphotropic virus 1 VK Sharma, V Raimondi, K Ruggero, CA Pise-Masison, I Cavallari, ... Frontiers in Microbiology 9, 358551, 2018 | 16 | 2018 |
| Mitochondrial proteins coded by human tumor viruses I Cavallari, G Scattolin, M Silic-Benussi, V Raimondi, DM D'Agostino, ... Frontiers in Microbiology 9, 325908, 2018 | 14 | 2018 |
| Comprehensive profiling of hypoxia-related miRNAs identifies miR-23a-3p overexpression as a marker of platinum resistance and poor prognosis in high-grade serous ovarian cancer P Todeschini, E Salviato, C Romani, V Raimondi, F Ciccarese, F Ferrari, ... Cancers 13 (13), 3358, 2021 | 10 | 2021 |
| 2-hydroxyglutarate in acute myeloid leukemia: a journey from pathogenesis to therapies V Raimondi, G Ciotti, M Gottardi, F Ciccarese Biomedicines 10 (6), 1359, 2022 | 9 | 2022 |
| A basic introduction to single particles cryo-electron microscopy. V Raimondi, A Grinzato AIMS Biophysics 9 (1), 2022 | 4 | 2022 |
| MiR-150 in HTLV-1 infection and T-cell transformation DM D’Agostino, V Raimondi, M Silic-Benussi, V Ciminale Frontiers in Immunology 13, 974088, 2022 | 3 | 2022 |
| STR profiling of HTLV-1-infected cell lines V Raimondi, S Minuzzo, V Ciminale, DM D’Agostino Human T-Lymphotropic Viruses: Methods and Protocols, 143-154, 2017 | 2 | 2017 |
| Repurposing Verapamil to Enhance Killing of T-ALL Cells by the mTOR Inhibitor Everolimus M Silic-Benussi, E Sharova, A Corradin, L Urso, V Raimondi, I Cavallari, ... Antioxidants 12 (3), 625, 2023 | | 2023 |
| Repurposing Verapamil to Enhance Killing of T-ALL Cells by the mTOR Inhibitor Everolimus. Antioxidants 2023, 12, 625 M Silic-Benussi, E Sharova, A Corradin, L Urso, V Raimondi, I Cavallari, ... | | 2023 |
| Role of miR-34a in HTLV-1-infected T-cells V Raimondi Università degli studi di Padova, 2017 | | 2017 |
